Two cases of serious hepatic injury caused by antithyroid drugs;Dwa przypadki istotnego uszkodzenia wa̧troby po leczeniu tyreostatykami

Endokrynologia Polska

Volumn 60, Issue 5, 2009, Pages 396-400

  Grzywa, Marek ^a   Orlowska Florek, Renata ^a   Grzywa Celińska, Anna ^b  

^a Oddzial Chorob Wewnetrznych Nefrologii I Endokrynologii Z Pracownia Medycyny Nuklearnej   (Poland)

^b Uniwersytet Medyczny   (Poland)

Author keywords

Antithyroid drugs; Liver toxicity; Radioiodine

Indexed keywords

IODINE 131; PREDNISONE; PROPYLTHIOURACIL; THIAMAZOLE; URSODEOXYCHOLIC ACID; ANTITHYROID AGENT; RADIOACTIVE IODINE;

ADULT; ARTICLE; CASE REPORT; DISEASE COURSE; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GRAVES DISEASE; HUMAN; JAUNDICE; LIVER INJURY; LIVER TOXICITY; THYROTOXICOSIS; TREATMENT OUTCOME; CHEMICALLY INDUCED DISORDER; MIDDLE AGED; TOXIC HEPATITIS;

ANTITHYROID AGENTS; DRUG-INDUCED LIVER INJURY; FEMALE; GRAVES DISEASE; HUMANS; IODINE RADIOISOTOPES; JAUNDICE; METHIMAZOLE; MIDDLE AGED; PREDNISONE; PROPYLTHIOURACIL;

EID: 72449195814     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Chan AO, Ng IO, Lam CM i wsp. Cholestatic jaundice caused by sequential carbimazole and propylthiouracil treatment for thyrotoxicosis. Hong Kong Med J 2003; 9: 377-380.
2. Ruiz JK, Rossi GV, Vallejos HA i wsp. Fulminant hepatic failure associated with propylthiouracil. Ann Pharmacother 2003; 37: 224-228.
3. Liaw YF, Huang MJ, Fan KD. Hepatic injury during propylthiouracil therapy in patients with hyperthyroidism: a cohort study. Ann Int Med 1993; 118: 424-428.
4. Cooper DS. Treatment of thyrotoxicosis. W: Braverman LE, Utiger RD (red.). Werner and Ingbar's the thyroid. Wyd. 7. Lippincott-Raven, Philadelphia 1997; 713-734.
5. Nakamura H, Noh JY, Koichi I i wsp. Comparison of metimazole and propylthiouracil in patients with hyperthyroidism caused by Graves disease. J Clin Endocrinol Metab 2007; 92: 2157-2162. (Pubitemid 46997115)
6. Kim HJ, Kim HB, Han YS i wsp. The incidence and clinical characteristics of symptomtic propylthiouracil-induced hepatic injury in patients with hyperthyroidism: a single-center retrospective study. Am J Gastroenterol 2001; 96: 165-169.
7. Ichiki Y, Akahoshi M, Yamashita N i wsp. Propylthioucacil-induced severe hepatitis: a case report and reviev of the literature. J Gastroenterol 1998; 33: 747-750.
8. Benyounes M, Semproux C, Daumierie C i wsp. Propylthiouracyl-induced severe liver toxicity: an indication for alanine aminotransferaze monitoring? World J Gastroenterol 2006; 12: 6232-6234.
9. Hartleb M. Polekowe uszkodzenia wa̧troby. Terapia 2008; 6: 67-74.
10. Williams KV, Nabak S, Becker D i wsp. Fifty years of experience with propylthiouracil-associated hepatotoxicity: what have we learned? J Clin Endocrinol Metab 1997; 82: 1727-1733.
11. Obolończyk Ł, Siekierska-Hellmann, Sworczak K. Powiklania leczenia interferonem alfa wirusowego zapalenia wa̧troby typu C ze szczególnym uwzglȩdnieniem funkcji tarczycy. Postȩpy Hig Med Dośw 2008; 62: 309-321.
12. Morris CV, Goldstein RM, Cofek JB i wsp. An unusual presentation of fulminant hepatic failure secondary to propylthiouracil therapy. Clin Transpl 1989; 311.
13. Sein Anand J, Chodorowski Z. Polekowe uszkodzenie wa̧troby po tiamazolu i metimazolu - opis przypadku. Przegl Lek 2007; 64: 4-5.
14. Waseem M, Seshadri KG, Kabadi UM. Successful outcome with methimazole and lithium combination therapy for propylthiouracil-induced hepatotoxicity. Endocr Pract 1998; 4: 197-200.
15. Brusco F, Gonzales G, Soto N i wsp. Successful treatment of hyperthyroidism with amiodarone in patient with propylthiouracil-induced acute hepatic failure. Thyroid 2004; 14: 862-865.